Citigroup Maintains Buy on Amrize, Lowers Price Target to $50

Benzinga Newsdesk www.benzinga.com Neutral 48.1%

Neg 0% Neu 48.1% Pos 0%

Citigroup analyst Anthony Pettinari maintains Amrize (NYSE:AMRZ) with a Buy and lowers the price target from $58 to $50.